Ryan Crisman

Chief Technical Officer • Umoja Biopharma

Ryan Crisman is the co-founder and Chief Technical Officer at Umoja Biopharma. Before starting Umoja in 2019, Ryan served as the Executive Director for the Gates Biomanufacturing Facility, where he was responsible for building out and staffing this protein and cell therapy CDMO. He was instrumental in growing the facility’s cGMP capabilities and delivering many first in human therapeutic products to patients. While at Juno Therapeutics, Ryan led the JCAR017 CMC program and was the Head of Late Stage Process Development. He has also held scientific leadership positions at Zymogenetics and CMC Biologics.

Crisman holds a Ph.D. in Chemical Engineering from the University of Colorado, Boulder, and a bachelor’s degree in Chemical Engineering from Washington State University.

Also Speaking

Scott Jones

Senior Vice President & Chief Scientific Officer • BioBridge Global

Lili Belcastro

Senior Principal Scientist, Cell and Gene Therapy Raw Materials • Bristol Myers Squibb

Suyash Prasad

Chief Medical Officer and Head of Research & Development • Taysha Gene Therapies

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.